Coldstream Capital Management Inc. Has $4.08 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Coldstream Capital Management Inc. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,162 shares of the medical equipment provider’s stock after selling 84 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Intuitive Surgical were worth $4,076,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Creekmur Asset Management LLC raised its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $26,000. Able Wealth Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth about $28,000. Delos Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC bought a new position in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Truist Financial increased their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a report on Tuesday, July 16th. Morgan Stanley boosted their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. BTIG Research increased their price target on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Finally, Citigroup boosted their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $446.45.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $481.80 on Tuesday. The firm has a 50-day moving average of $459.60 and a 200-day moving average of $419.17. The stock has a market cap of $170.89 billion, a PE ratio of 86.53, a PEG ratio of 5.20 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. Intuitive Surgical’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.18 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,458,979.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,717 shares of company stock valued at $24,743,576. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.